Newsletters

12.21.16

VR Holiday Check-In

Around this time last year we were all looking forward to what we thought would be the biggest year yet for VR, when consumers would finally be able to get their hands on the major U.S. headsets. The year 2016 was indeed a major milestone in the timeline of VR, marked with a lot of experimentation, ...


12.21.16

Capping Federal Medicaid Funding: Key Financing Issues for States

President-elect Donald Trump and Republican congressional leadership have called for a repeal of the Affordable Care Act (ACA) and a fundamental overhaul of the Medicaid program that would include imposing caps on federal funding to states.


12.21.16

CFPB Warns Financial Institutions About Incentives

Use caution when creating incentives for employees and service providers to meet sales and other business goals, the Consumer Financial Protection Bureau warned financial institutions in a new Compliance Bulletin.


12.21.16

CFPB Warns Financial Institutions About Incentives

Use caution when creating incentives for employees and service providers to meet sales and other business goals, the Consumer Financial Protection Bureau warned financial institutions in a new Compliance Bulletin.


12.20.16

Defendant’s Attempt to Moot TCPA Suit Fails (Again)

A Telephone Consumer Protection Act defendant was unsuccessful in persuading a Massachusetts federal court judge to dismiss a putative class action under the statute despite offering the plaintiff $46,500 and promising to refrain from future violations.


12.20.16

Manatt on Health Reform: Weekly Highlights, December 20, 2016

The National Association of Medicaid Directors offers policy considerations and recommendations to the incoming Administration; HealthCare.gov has its largest single day of enrollment ever; and new publications prepared by Manatt Health compare ACA replacement proposals and highlight the potential ...


12.19.16

How Retailers Can Avoid Regulatory Scrutiny During Holiday Season

With the holiday season often accounting for one-third of a retailer’s annual sales, competition can be fierce. Tempting as it is to grab for every advantage, this can have the unpleasant consequence of legal entanglements with the Federal Trade Commission (FTC) or a state attorney general ...


12.19.16

Balancing Gene Therapy’s Promise and Price

Gene therapy is the therapeutic delivery of polymers into a patient’s cells for the purpose of treating a disease. Polymers interfere with gene expression or correct mutations.


12.19.16

Telehealth for Healthy Competition

As providers look for more convenient and cost-effective means to reach patients, there has been much discussion about the potential benefits of telehealth services. Such services also are healthy from an antitrust perspective. Against a backdrop of regular advocacy in favor of lowering barriers to ...


12.19.16

California Court Expands Roadmap for “Reasonable Value” of Providers’ Services

Health plans generally are obligated to pay out-of-network providers only the “reasonable value” of their services and not their full billed charges, which often are higher.